Talk:Bruce Roth

Please, BLP-experienced editors, take necessary steps, Tags added because this reads like a CV

This article has a single inline citation, to a public record (primary source), to support a personal detail.

Otherwise, it appears to contain no inline citations to any secondary source. Instead, it contains a list of citations that fails, in significant ways to support key contentions in the article (e.g., by not providing any support for biographical detail, for lack of independent secondary sourcing to support claim of sole party discoveries, etc.).

This is a BLP article, and per WP BLP policies, must be held to the highest standards of sourcing. Were I to delete the whole thing, it would be Wikipedia policy to not allow its reintroduction without proper sourcing.

I have no desire to disrespect the esteemed Bruce Roth. But this cannot remain as a WP biography page, as it is. (It looks suspiciously like an article posted by friend or close colleague, and this place demands sourced material, independent and secondary.)

Tags are places accordingly. Note, I invite BLP-experienced editors: please feel free to modify the tags, so the article tags are reduced, but it still receives proper attention, and remains tagged until its issues are corrected. Le Prof Leprof 7272 (talk) 23:20, 14 June 2014 (UTC)

I see a relatively short article with 10 sources listed, which is above average. Most of the sources are quite good, and I don't understand the neutrality tag at all. He's notable for discovering a major drug and for being a major influence in the field of medicinal chemistry. Is there negative information of note that has been excluded? I'm not aware of any. Removed all of the tags. Formerly 98 (talk) 15:28, 12 January 2015 (UTC)

More simply put, the article, which had one URL-only citation at the time of its tagging, has evolved to be a relatively well-sourced short BLP article. Hence, it was appropriate for @Formerly 98: to remove the tags. At the time of its tagging, it certainly was in need of them ( see [1]) and this is a great case-in-point, where the early WP design of tags to improve articles has shown its value. Cheers, Le Prof 50.179.252.14 (talk) 16:42, 2 February 2016 (UTC)

Award

In 1985 Roth "identified a molecule" that inhibited HMG CoA reductase, a "key enzyme in the metabolic pathway the body uses to produce cholesterol."

"Senior vice president, small molecule drug discovery at Genentech, is the recipient of the 2015 NAS Award for Chemistry in Service to Society. In 1985 while at Parke-Davis Pharmaceutical Research, Roth identified a molecule that inhibited HMG CoA reductase, a key enzyme in the metabolic pathway the body uses to produce cholesterol. Roth and his colleagues worked to synthesize the enzyme-inhibiting molecule and transform it into a viable drug, atorvastatin, sold under the brand name Lipitor. People with high levels of low-density lipoprotein (LDL) cholesterol have an increased risk of heart disease, the biggest killer of men and women in the United States. Studies showed that Lipitor could not only lower cholesterol but also delay or even prevent heart attacks. Those results helped make Lipitor the world’s leading cholesterol-lowering drug, taken by millions of people."

— National Academy of Sciences 2015

[Unsigned edit by User:Oceanflynn, 16:42, 16 November 2015‎]